RA Padua
RA Padua
Universite Paris-Diderot
Verified email at inserm.fr - Homepage
Cited by
Cited by
Activated ras oncogenes in human thyroid cancers
NR Lemoine, ES Mayall, FS Wyllie, CJ Farr, D Hughes, RA Padua, ...
Cancer research 48 (16), 4459-4463, 1988
FMS mutations in myelodysplastic, leukemic, and normal subjects.
SA Ridge, M Worwood, D Oscier, A Jacobs, RA Padua
Proceedings of the National Academy of Sciences 87 (4), 1377-1380, 1990
RAS, FMS and p53 mutations and poor clinical outcome in myelodysplasias: a 10-year follow-up
RA Padua, BA Guinn, AI Al-Sabah, M Smith, C Taylor, T Pettersson, ...
Leukemia 12 (6), 887-892, 1998
RAS mutations in myelodysplasia detected by amplification, oligonucleotide hybridization, and transformation.
RA Padua, G Carter, D Hughes, J Gow, C Farr, D Oscier, F McCormick, ...
Leukemia 2 (8), 503-510, 1988
Reactive oxygen species, DNA damage, and error-prone repair: a model for genomic instability with progression in myeloid leukemia?
FV Rassool, TJ Gaymes, N Omidvar, N Brady, S Beurlet, M Pla, M Reboul, ...
Cancer research 67 (18), 8762-8771, 2007
Multidrug resistance in haemopoietic cell lines, myelodysplastic syndromes and acute myeloblastic leukaemia
J Holmes, A Jacobs, G Carter, A Janowska‐wieczorek, RA Padua
British Journal of Haematology 72 (1), 40-44, 1989
A novel transforming gene in a human malignant melanoma cell line
RA Padua, N Barrass, GA Currie
Nature 311 (5987), 671-673, 1984
The molecular basis of myelodysplastic syndromes
A Gallagher, RL Darley, RA Padua
haematologica 82 (2), 191-204, 1997
Nanofluidic proteomic assay for serial analysis of oncoprotein activation in clinical specimens
AC Fan, D Deb-Basu, MW Orban, JR Gotlib, Y Natkunam, R O'neill, ...
Nature medicine 15 (5), 566-571, 2009
Increased circulating colony-stimulating factor-1 in patients with preleukemia, leukemia, and lymphoid malignancies
A Janowska-Wieczorek, AR Belch, A Jacobs, D Bowen, RA Padua, ...
Histone deacetylase inhibitors (HDI) cause DNA damage in leukemia cells: a mechanism for leukemia-specific HDI-dependent apoptosis?
TJ Gaymes, RA Padua, M Pla, S Orr, N Omidvar, C Chomienne, GJ Mufti, ...
Molecular cancer research 4 (8), 563-573, 2006
Activation of N-ras in a human melanoma cell line.
RA Padua, NC Barrass, GA Currie
Molecular and cellular biology 5 (3), 582-585, 1985
Cytogenetic abnormalities in the myelodysplastic syndromes and occupational or environmental exposure
RR West, DA Stafford, AD White, DT Bowen, RA Padua
Blood, The Journal of the American Society of Hematology 95 (6), 2093-2097, 2000
Frequent expression of HAGE in presentation chronic myeloid leukaemias
SP Adams, SS Sahota, A Mijovic, B Czepulkowski, RA Padua, GJ Mufti, ...
Leukemia 16 (11), 2238-2242, 2002
Clonal lymphocytes are detectable in only some cases of MDS
DJ Culligan, P Cachia, J Whittaker, A Jacobs, RA Padua
British journal of haematology 81 (3), 346-352, 1992
PML-RARA–targeted DNA vaccine induces protective immunity in a mouse model of leukemia
RA Padua, J Larghero, M Robin, C le Pogam, MH Schlageter, S Muszlak, ...
Nature medicine 9 (11), 1413-1417, 2003
Multidrug resistance in leukaemia
SL McKenna, RA Padua
British journal of haematology 96 (4), 659-674, 1997
ras mutations in human melanotic lesions: K-ras activation is a frequent and early event in melanoma development.
VK Shukla, DC Hughes, LE Hughes, F McCormick, RA Padua
Oncogene research 5 (2), 121-127, 1989
Mutant N-RAS Induces Erythroid Lineage Dysplasia in Human CD34+ Cells
RL Darley, TG Hoy, P Baines, RA Padua, AK Burnett
The Journal of experimental medicine 185 (7), 1337-1348, 1997
Plasmodium chabaudi: genetics of resistance to chloroquine
RA Padua
Experimental parasitology 52 (3), 419-426, 1981
The system can't perform the operation now. Try again later.
Articles 1–20